Wound management is an essential process that involves the proper care and treatment of wounds to prevent infection, promote healing, and reduce scarring. Proper wound management involves cleaning and dressing the wound, controlling bleeding, preventing infection, and promoting healing. The cause of the skin break will need to be fully addressed for many complicated wounds to allow healing to occur.
Wound management for diabetic foot ulcers will require a multidisciplinary approach. Blood sugar needs to be regulated with dietary changes and medication management. Offloading is a common need to allow foot wounds to heal and often result in long term use of specialty shoes. Mobility may be affected if weight bearing on the foot is restricted which leads to the need for durable medical equipment and physical therapy.
When circulatory changes limit blood flow, surgical interventions are often required to bring adequate blood flow to a distal wound area for healing. If circulation issues are caused by venous disease, external compression becomes another intervention needed. Compression can be in the form of garments and the use of sequential pumping devices. Compression may become a lifetime need to maintain healthy vessel support especially when edema becomes chronic or lymphedema is present. Infection also becomes an issue when circulation and poor skin integrity are combined and compounded by poor hygiene or household care.
The dressings used to manage open wounds will depend on many factors. The amount of drainage, where the wound is located on the body and how the skin reacts to products used must all be considered when making a treatment plan. Good wound management accounts for these factors and adjusts as needed. Drainage will likely decrease over time. The dressing should be adjusted to maintain optimal moisture balance. Everyone’s skin is different and not all can tolerate adhesive bandages. Irritation from tape can cause lots of discomfort and further skin breakdown. The use of compression often results in poor compliance for many people as application of garments can be difficult and cumbersome. Regardless, to heal wounds where there is venous insufficiency or lymphedema, compression will be an essential part of the treatment plan.
Developing a wound management plan must take into consideration the direct needs of the wound but also the person who has the wound and the caregivers that will provide care. People have needs that might include: cost of supplies, how often the dressing is changed, what the dressing looks like and how complicated the wound care regimen is going to be. Finding a perfect balance for optimal compliance is ideal and leads to the best experience for all parties involved. When an individual has multiple health-related issues compounded by mobility issues and lack of caregiver support, the complicating factors are compounded.
Managing a wound also includes managing expectations. People want the process to be fast but not all wounds will progress quickly. Individuals can do a lot to support their own healing in between medical office visits. Healthy habits like adequate nutrition, hydration and exercise while following any restrictions provided will go a long way to helping an individual improve their situation. However, not all wounds will heal especially as people near end-of-life stages and wounds may even decline as general health declines. Caregivers often carry a lot of the load of wound management in the home which can be a daunting task as the health of their person begins to fail. Knowing what to expect and how to manage wounds that are not expected to heal can help with the burden.
Compliance and communication is key. Facilities will provide caregiver training for wound management. Communicating when the care plan is too difficult to manage or issues arise leaves the medical team the opportunity to provide more guidance and to make adjustments to help heal. There are thousands of products on the market from different dressings, turning and positioning devices and mobility aides that can be considered for the best possible outcomes to be obtained.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Patent for collagen processing is issued
First collagen veterinary products are developed
Kollagen™ is developed- the world’s first collagen wound care dressings are cleared by the FDA
HBS receives several research grants
New headquarters established in Maryland
HBS is founded by Manoj. K. Jain in Kansas.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.